A comparison of the local anaesthetic-, "quinidine-like"- and adrenergic beta-blocking-activities of five beta-receptor antagonists.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology; D000779:Anesthetics, Local / Q000494:pharmacology*; D000813:Anilides / Q000494:pharmacology; D000818:Animals; D003964:Diaphragm / Q000187:drug effects; D004983:Ethanolamines / Q000494:pharmacology*; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D066298:In Vitro Techniques; D009469:Neuromuscular Junction / Q000187:drug effects; D009578:Nitrobenzenes / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D010791:Phrenic Nerve / Q000187:drug effects; D011433:Propranolol / Q000494:pharmacology*; D011802:Quinidine; D051381:Rats; D012867:Skin / Q000187:drug effects; D013451:Sulfonic Acids / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D000779:Anesthetics, Local; D000813:Anilides; D004983:Ethanolamines; D009578:Nitrobenzenes; D010627:Phenethylamines; D013451:Sulfonic Acids; D013565:Sympatholytics; D011433:Propranolol; D011802:Quinidine